Institutions bought Pingtan Development and 17 other stocks today, selling Eastroc Beverage for 363 million yuan36Kr·Mar 31 at 05:25 AM688308+5.76%605499-1.66%
"A-Share Focus" Staidson BioPharm plummets 8.5%, the third-largest shareholder plans to reduce holdingsetnet·Nov 5, 2025 at 08:33 PM300204+4.92%
Staidson BioPharm today hit a 20% limit up, with 5 institutional special seats net buying 229 million yuanZhitong·Oct 31, 2025 at 03:25 AM300204+4.92%
Staidson BioPharm released its performance for the first three quarters, with a net loss attributable to the parent company of 30.6895 million yuanZhitong·Oct 28, 2025 at 05:56 AM300204+4.92%
Staidson BioPharm: Application for stock issuance to specific objects accepted by Shenzhen Stock ExchangeZhitong·Oct 26, 2025 at 03:17 AM300204+4.92%
Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit upZhitong·Oct 16, 2025 at 08:44 PM300683+7.29%002004+0.68%
The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%Zhitong·Sep 25, 2025 at 08:33 PM300204+4.92%600276-1.04%
10 drugs have been suspended from procurement qualifications, involving Staidson BioPharm, Baillie Pharmaceutical, and other companiesZhitong·Sep 17, 2025 at 01:59 AM300204+4.92%
The concept of innovative drugs has rebounded, with Chimin gaining 6 limit-ups in 12 days, Staidson BioPharm rising over 7%, Hotgen increasing over 5%, and stocks like Medicilon, Cosunter, and BrightGene also seeing gainsZhitong·Sep 10, 2025 at 09:20 PM603222+2.29%300204+4.92%
Staidson BioPharm: Xiangtang Group reduced its holdings by 3.3607 million shares of the companyZhitong·Sep 10, 2025 at 05:42 AM300204+4.92%
Staidson BioPharm plans to raise no more than 1.253 billion yuan through a private placement of sharesZhitong·Sep 9, 2025 at 04:09 AM300204+4.92%
2025 Fund Mid-Year Report Insight: Pharmaceuticals, Banks, and Electronics Become Key Areas for Increased Holdings, Staidson BioPharm Fund's Shareholding Ratio Ranks FirstZhitong·Sep 2, 2025 at 01:36 AM002940+3.97%300204+4.92%
Innovative drug concept stocks fell in the afternoon, with Staidson BioPharm down over 10%Zhitong·Sep 2, 2025 at 12:17 AM002940+3.97%300158+1.44%
